CAS No. |
466-75-1 |
中文名称 |
(3S,4aS,11bS,12R)-3-甲氧基-4,4a-二氢-3H,6H-11b,5-乙烷桥并[1,3]二氧杂环[4,5-j]菲并吡啶-12-醇 |
英文名称 |
(3S,4aS,11bS,12R)-3-methoxy-4,4a-dihydro-3H,6H-11b,5-ethano[1,3]dioxolo[4,5-j]phenanthridin-12-ol |
别名 |
VBL6HZX2ZB | 3-Epicrinamine | 3-epi-Crinamine | SCHEMBL19915195 | NSC403140 | NSC-403140 | BDBM50221069 | 4a.beta.,11b.alpha.-Crinan-12-ol, 1,2-didehydro-3.beta.-methoxy-, (12R)- | XH175863 | Natalensine (+)-Haemanthamine | Hemeanthamin | Crinan-11-ol, 1, |
标准英文名 |
(3S,4aS,11bS,12R)-3-methoxy-4,4a-dihydro-3H,6H-11b,5-ethano[1,3]dioxolo[4,5-j]phenanthridin-12-ol |
分子式 |
C17H19NO4 |
分子量 |
301.34
|
精确分子量 |
301.13
|
SMILES |
CO[C@@H]1C=C[C@@]23C4=CC5=C(C=C4CN(C[C@@H]2O)[C@H]3C1)OCO5 |
标准SMILES |
CO[C@H]1C[C@@H]2N3CC4=CC5OCOC=5C=C4[C@]2(C=C1)[C@@H](O)C3 |
用途 |
Haemanthamine exhibits potent anticancer activity by targeting the ribosome and inhibiting protein biosynthesis at the elongation phase of translation; it demonstrates pro-apoptotic, antioxidant, antiviral, antimalarial, and anticonvulsant activities; it significantly inhibits proliferation and reduces viability of A2780 ovarian cancer cells in a time- and dose-dependent manner; it specifically inhibits pre-rRNA processing, thereby activating the p53-dependent nucleolar stress pathway; it shows favorable pharmacokinetic properties with rapid distribution, high intracellular penetration, and sustained plasma concentrations above 1 μM for at least 1 hour after a single 10 mg/kg dose in rats. |
InChIKey |
YGPRSGKVLATIHT-HSHDSVGOSA-N |